Physician
Children's Health PM Urgent Care, PLLC
Children's Health PM Urgent Care, PLLC was paid $13.51M by Medicaid between Nov 2019 and Dec 2024, across 31 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoCHILDREN'S HEALTH PM URGENT CARE, PLLC
THE COLONY, TX 75056
THE COLONY, TX 75056
33aNPI1275013955assigned 08/21/2018
33bProvider typePediatric Emergency Medicine (Pediatrics) Physician
28Total paid$13.51M
24GClaims145,135
24DCodes billed31
24AFirst – last monthNov 2019 – Dec 2024
Compared with peers
Next to other Pediatric Emergency Medicine (Pediatrics) Physician providers in Texas
Rank by total paid#1 of 12
Median peer was paid$18K
This provider vs. median739×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 15 | $0.00 | |
| 2020 | 3,896 | $208K | |
| 2021 | 24,027 | $1.34M | |
| 2022 | 52,566 | $4.03M | |
| 2023 | 31,722 | $3.49M | |
| 2024incomplete | 32,909 | $4.44M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 33,506 | 30,619 | $3.97M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 31,204 | 28,250 | $3.55M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 24% | 27,445 | 26,269 | $3.29M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 19% | 22,758 | 21,358 | $2.62M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 193 | 190 | $26K |
| 99205 | Prolong outpt/office vis | <1% | 169 | 168 | $25K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 4,012 | 3,170 | $16K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 84 | 80 | $11K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 39 | 39 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,574 | 5,830 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,508 | 2,235 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 85 | 81 | $271.89 |
19 more codes
| 87428 | <1% | 54 | $216.80 | |
| 73110 | <1% | 27 | $165.60 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 155 | $70.00 |
| 81003 | <1% | 1,166 | $34.02 | |
| 99000 | <1% | 3,972 | $32.40 | |
| 69209 | <1% | 14 | $24.70 | |
| 87807 | <1% | 56 | $11.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 105 | $0.85 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 103 | $0.44 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 58 | $0.36 |
| 99051 | 0% | 6,478 | $0.00 | |
| S9083 | Global fee urgent care centers | 0% | 142 | $0.00 |
| 99072 | 0% | 90 | $0.00 | |
| 73140 | 0% | 12 | $0.00 | |
| J7699 | Noc drugs, inhalation solution administered through dme | 0% | 12 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 1,450 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 638 | $0.00 |
| 36416 | 0% | 14 | $0.00 | |
| 82962 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSIMPSON, MARLENA (SR. DIRECTOR, CRED & ENROLLMENT)